Pediatric Poisoning by Ingestion: Developmental Overview and Synopsis of National Trends

Pediatric Annals
|December 12, 2017
PubMed

Insights

Pediatric ingestions are common, often exploratory, and pose risks throughout childhood. Healthcare providers can guide caregivers on preventing poisonings linked to developmental stages.

Area of Science:

  • Toxicology
  • Pediatrics
  • Epidemiology

Background:

  • Pediatric ingestions represent a significant portion of reports to the American Association of Poison Control Centers' National Poison Data Surveillance System.
  • Children's developmental stages, from early childhood to adolescence, increase their vulnerability to various poisonous ingestions.
  • Exploratory behavior is a primary driver for most pediatric ingestion incidents.

Purpose of the Study:

  • To highlight the role of pediatric providers in preventing poisonings.
  • To inform caregivers about age-specific risks and developmental milestones related to ingestions.
  • To underscore the importance of real-time toxico-surveillance data.

Main Methods:

  • Utilizing data from the American Association of Poison Control Centers' National Poison Data Surveillance System.
  • Analyzing trends in pediatric ingestions based on developmental stages.
  • Reviewing common agents associated with pediatric fatalities.

Main Results:

  • Pediatric ingestions are a major component of poison control center reports.
  • Developmental milestones correlate with specific ingestion risks.
  • Common fatal agents include disc batteries, laundry pods, opioids, acetaminophen, benzodiazepines, and amphetamines.

Conclusions:

  • Pediatric providers are crucial resources for anticipatory guidance on preventing ingestions.
  • Caregivers need targeted information relevant to their child's developmental phase.
  • Understanding developmental vulnerability is key to reducing pediatric poisoning incidents.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
15
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
17
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.3K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
18